Nuscale Power

Search documents
Faruqi & Faruqi Reminds Elevance Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 11, 2025 - ELV
Prnewswire· 2025-06-20 15:20
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $100,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 20, 2025 /PRNewsw ...
BROAD ARROW ADDS THE FOURTH SHELBY COBRA EVER BUILT, CSX 2003, TO MONTEREY JET CENTER AUCTION
Globenewswire· 2025-06-20 15:18
REMARKABLY PRESERVED 1962 SHELBY 260 COBRA, ONE OF THE ORIGINAL PROTOTYPE EXAMPLES, OFFERED FROM 36 YEARS OF CHERISHED LONGTERM OWNERSHIP | COBRA JOINED BY MODERN AMERICAN AUTOMOTIVE LEGENDS: HENNESSEY VENOM GT AND THE AMERICAN PERFORMANCE COLLECTION OF DODGE AND CHEVROLET ICONS The 1962 Shelby 260 Cobra, CSX 2003, to be offered at Broad Arrow’s 2025 Monterey Jet Center Auction (Credit – Andrew Benjack / Courtesy of Broad Arrow Auctions) A pair of limited-edition Dodge Vipers offered from The American ...
Notice on the Extraordinary General Meeting of Shareholders of the AUGA group, AB entity under restructuring on 14 July 2025 to approve the Company’s draft restructuring plan
Globenewswire· 2025-06-20 15:15
AUGA group, AB entity under restructuring (code 126264360, registered office at Konstitucijos pr. 21C, Vilnius, hereinafter referred to as the “Company”), by the initiative and decision of the Board, is convening an Extraordinary General meeting of shareholders on July 14, 2025, at 10:00 a.m., where the Company’s shareholders will vote on the approval of the Company’s draft restructuring plan, hereinafter referred to as the “Meeting”. The Meeting will be held at the conference room at the business center Q ...
理想超充站2505座|截至25年6月20日
理想TOP2· 2025-06-20 15:10
重庆市 大足区 万古服务区(广泸高速广安方向) 为高速服务区5C站,规格:2C × 6 5C × 2 重庆市 【附】3 座新增建成 北京市 丰台区 北京万芳亭公园 为城市/商业中心2C站,规格:2C × 4 (tim cook 直呼内行) 大足区 万古服务区(广泸高速泸州方向) 为高速服务区5C站,规格:2C × 6 5C × 2 来源: 北北自律机 25年06月20日星期五 理想超充 3 新增。 超充建成数:2502→2505座 加微信,进群深度交流理想长期基本面。不是车友群。 基于2025年底4000+座目标 今年新增数进度值:34.10%→34.23% 今年剩余194天 今年时间进度值:46.85% 需每日 7.71 座,达到年底目标值 ———————————————————— ...
理想i6月销不一定会输小米YU7
理想TOP2· 2025-06-20 15:10
TOP2对理想i6月销预期为18-30K,认为YU7月销有可能低于28K(注意不指必然),故认为理想i6月 销不一定会输YU7。 25年6月说i6月销不一定输YU7,在舆情维度有点像在24年3月说SU7月销不一定输L6。 24年4月-25年5月,SU7共交付271954,L6交付269759。SU7第一次月销超L6是25年1月,并一直维持 到5月。TOP2非常确定,25年 SU7的的确确实实在在抢了一部分本来打算买L6的用户,无法定量分 析,但量可能在一个月2k+。 YU7较SU7空间的确明显提升,操控大概率有所下降,SU7有很强的颜值加成。YU7在同车下绝对不 是最大空间。 SU7抢的是20-30万价位,最值得买的新能源车的生态位。 i6背后是同车长下最大内部空间,同价位下最好的纯电综合补能体验/最佳舒适度+很不错的操控/极具 竞争力的座舱与智驾体验,叠加两驱会进一步降低最低售价,由MEGA/i8来做价值锚点。 YU7背后是跨价位段极优秀的SUV颜值/跨价位段非常高的两驱纯电续航/可能会和Model Y同级别的 操控/内饰视觉高级感维度可能会明显比i6强/最低配智驾硬件可能会比i6强,由SU7作为销量锚点。 ...
Will BigBear.ai's $384.9M Backlog Drive H2 Acceleration?
ZACKS· 2025-06-20 15:10
Key Takeaways BBAI's backlog rose 30% year over year to $384.9M, driven by long-term national security contracts. Revenue growth is expected to accelerate in H2 2025, averaging 6.8% versus 4% in H1. BBAI retained its 2025 revenue outlook of $160M-$180M, projecting up to 13.8% year-over-year growth.BigBear.ai Holdings, Inc.’s (BBAI) AI-based portfolio of offerings is at a juncture where the demand for national security and mission-critical needs meet. The increasing spending by the United States on travel, ...
Faruqi & Faruqi Reminds Fortrea Holdings Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 - FTRE
Prnewswire· 2025-06-20 15:10
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 20, 2025 /PRNewswire/ ...
Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?
ZACKS· 2025-06-20 15:06
Key Takeaways Pfizer's oncology sales make up 25% of total revenues, boosted by its 2023 Seagen acquisition. Bristol Myers expands its oncology pipeline with Mirati and RayzeBio acquisitions and new drug approvals. PFE shows better stock performance and a 7.2% dividend yield, edging out BMY's 5.29% amid valuation parity.Pharma/biotech giants Pfizer (PFE) and Bristol Myers (BMY) boast of a dominant position in the lucrative oncology space.Oncology or cancer is one of the most sought-after areas in the phar ...
Here's Why Investors Should Retain Flowserve Stock in Portfolio
ZACKS· 2025-06-20 15:06
Key Takeaways FLS saw Q1 2025 revenue growth in Pumps and Flow Control, with bookings up 21.2% and 10.2, respectively. MOGAS acquisition added 3.3% to Q1 sales and strengthened FLS's valve, automation and mining exposure. Higher input and costs, along with $1.45B in debt, pressured margins and investor confidence.Flowserve Corporation (FLS) has been experiencing strong momentum in the Pump Division and Flow Control Division segments. Strength in the aftermarket business, driven by a strong demand for prod ...
Accenture Earnings Beat Estimates in Q3, Revenues Increase Y/Y
ZACKS· 2025-06-20 15:06
Key Takeaways ACN reported Q3 EPS of $3.49 and revenues of $17.7B, both beating estimates. Consulting and managed services revenues rose 7% and 9% y/y, respectively, beating internal forecasts. ACN raised the FY25 revenue and free cash flow guidance, indicating a strong Q3 operating performance.Accenture plc (ACN) has reported impressive third-quarter fiscal 2025 results, wherein earnings and revenues surpassed the Zacks Consensus Estimates.ACN’s earnings were $3.49 per share, beating the Zacks Consensus ...